Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Sort by
831 items
-
Business - The Wall Street Journal
Pfizer's Hympavzi Approved for Treatment of Certain Types of Hemophilia
The FDA approved Pfizer’s Hympavzi, which can be an alternative to intravenous infusions often administered multiple times a week.October 11 -